Literature DB >> 17679650

Is there an unrecognized epidemic of primary aldosteronism? Con.

Norman M Kaplan1.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17679650     DOI： 10.1161/HYPERTENSIONAHA.106.086124

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  9 in total

Review 1.  Primary aldosteronism.

Authors:  Richard J Auchus; Fiemu E Nwariaku
Journal:  Curr Cardiol Rep       Date:  2007-11       Impact factor: 2.931

Review 2.  Update in new medications for primary care.

Authors:  Gerald W Smetana; Jane S Sillman
Journal:  J Gen Intern Med       Date:  2008-11-13       Impact factor: 5.128

Review 3.  Screening for adrenal-endocrine hypertension: overview of accuracy and cost-effectiveness.

Authors:  Gary L Schwartz
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

4.  Double hit! A unique case of resistant hypertension.

Authors:  Kristen Elizabeth DeCarlo; Nidhi Agrawal
Journal:  BMJ Case Rep       Date:  2017-12-22

Review 5.  Aldosterone and arterial hypertension.

Authors:  Andreas Tomaschitz; Stefan Pilz; Eberhard Ritz; Barbara Obermayer-Pietsch; Thomas R Pieber
Journal:  Nat Rev Endocrinol       Date:  2009-12-22       Impact factor: 43.330

Review 6.  Primary aldosteronism: from bench to bedside.

Authors:  Norlela Sukor
Journal:  Endocrine       Date:  2011-11-01       Impact factor: 3.633

7.  Some considerations about evolution of idiopathic primary aldosteronism.

Authors:  D Armanini; C Fiore
Journal:  J Endocrinol Invest       Date:  2009-07       Impact factor: 4.256

8.  Common secondary causes of resistant hypertension and rational for treatment.

Authors:  Charles Faselis; Michael Doumas; Vasilios Papademetriou
Journal:  Int J Hypertens       Date:  2011-03-02       Impact factor: 2.420

9.  Changes in the perceived epidemiology of primary hyperaldosteronism.

Authors:  Riccardo Maria Fagugli; Chiara Taglioni
Journal:  Int J Hypertens       Date:  2011-08-04       Impact factor: 2.420
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.